Daniel E. Hilleman, PharmD, FCCP

home / authors / daniel-e-hilleman-pharmd

Articles

Hypertension: A Silent Killer Requiring Novel Therapies

Shanna L. Jansen, PharmD Candidate;Mark A. Malesker, PharmD, FCCP, FCCM, FASHP, BCPS;Daniel E. Hilleman, PharmD, FCCP

July 19th 2025

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Daniel E. Hilleman, PharmD, FCCP

December 11th 2012

This review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com

Published: June 12th 2025 | Updated: June 16th 2025

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers

Published: June 10th 2025 | Updated: June 12th 2025

Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members

Published: June 2nd 2025 | Updated: June 11th 2025

NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care

Published: June 3rd 2025 | Updated: June 11th 2025

ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape

Published: May 30th 2025 | Updated: June 5th 2025

Emerging Data: Impacts of ROCKstar and AGAVE-201

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com

Published: April 18th 2025 | Updated: April 21st 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Do Not Sell My Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777

Daniel E. Hilleman, PharmD, FCCP

Articles

Latest Updated Articles